
ISRG · NASDAQ
Intuitive Surgical, Inc.
$452.29 +8.43 (+1.90%)
Company overview
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach, and the Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Exchange
- NASDAQ
- Market cap
- $160B
- Employees
- 15,638
- Headquarters
- Sunnyvale, CA
- Website
- intuitive.com
- CEO
- David J. Rosa
- Listed
- June 16, 2000
- P/E
- 54.00
- Dividend yield
- 0.00%
Company financials
- Revenue
- $10.6B
- Gross profit
- $7B
- Operating income
- $3.2B
- EBITDA
- $3.8B
- Net income
- $3B
- EPS
- $8.37
- Total assets
- $20.1B
- Total debt
- $0.00
- Gross margin
- 66.29%
- Net margin
- 28.15%
- Earnings yield
- 1.85%
Showing FY 2025